The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
R-ALPS: A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of TQB2450 with or without anlotinib as maintenance treatment in patients with locally advanced and unresectable (stage III) NSCLC without progression following concurrent or sequential chemoradiotherapy.
 
Ming Chen
No Relationships to Disclose
 
Yongling Ji
No Relationships to Disclose
 
Long Chen
No Relationships to Disclose
 
Qingsong Pang
No Relationships to Disclose
 
Ou Jiang
No Relationships to Disclose
 
Hong Ge
No Relationships to Disclose
 
Yufeng Cheng
No Relationships to Disclose
 
Rongrong Zhou
No Relationships to Disclose
 
Xiangjiao Meng
No Relationships to Disclose
 
Xuhong Min
No Relationships to Disclose
 
Hui Wang
No Relationships to Disclose
 
Haihua Yang
No Relationships to Disclose
 
Yue Xie
No Relationships to Disclose
 
Anping Zheng
No Relationships to Disclose
 
Jie Li
No Relationships to Disclose
 
Bing Xia
No Relationships to Disclose
 
Desheng Hu
No Relationships to Disclose
 
Xi Zhang
No Relationships to Disclose
 
Yong Chen
No Relationships to Disclose
 
Wenhui Li
No Relationships to Disclose